IABCN Ambassador Club Member, InVivo’s Device May Spark Rally In The Shares
Yahoo! News – On Friday, November 7, 2014, we wrote an article providing a brief update on InVivo Therapeutics (NVIV). In the article, we noted that the first patient was enrolled in the company’s pilot study of its Neuro-Spinal Scaffold (NSS) for the treatment of complete traumatic spinal cord injury on October 15, 2014. The subject, who we now know to be 25 year old Jordan Fallis of Arizona, was the first human to receive InVivo’s NSS device at the Barrow Neurological Institute at St. Joseph’s Hospital and Medical Center in Phoenix, AZ.
Back in October, Dr. Nicholas Theodore, Chief of Spinal Surgery, Barrow Neurosurgical Institute and Medical Director of the Neurological Trauma Program performed the surgery and commented that the procedure went smoothly and the patient was doing well following surgery. Yesterday, November 11, 2014, Barrow press released news of the surgery, beginning what we believe will be a media frenzy over the next several weeks as news of Jordan’s recovery leaks out.
To read the entire article, please click HERE.